Jerusalem Pharmaceuticals Co. Ltd. (PLSE: JPH)
Health Care · Pharmaceuticals · PS
$3.50
-0.85% today · +83.7% 1Y
Jerusalem Pharmaceuticals Co. Ltd. (PLSE: JPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $126.00M.
Over the last twelve months the share price has gained 83.7%, trading between 1.90 and 4.00.
Tweenvest scores Jerusalem Pharmaceuticals Co. Ltd. across four factors: quality 79/100, value 50/100, growth 58/100, dividend 78/100. Its strongest factor is quality.
JPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $126.00M
- Revenue (TTM)
- $51.36M
- P/E
- 12.75
- EPS
- 0.27
- Dividend yield
- 2.14%
- Beta (5Y)
- 0.41
- 52-week high
- $4.00
- 52-week low
- $1.90
- Avg volume (3M)
- —
- Shares outstanding
- 36.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BIOBIJOU Co.,Ltd.KOSDAQ: A489460 | $129.60M | ₩11,810.00 | +2.43% |
| MPH Health Care AGDB: 93M1 | $128.48M | €26.80 | +1.13% |
| Sunhawk Vision Biotech, Inc.TPEX: 7759 | $126.93M | NT$57.70 | +35.61% |
| JW Lifescience CorporationKOSE: A234080 | $126.01M | ₩10,940.00 | -0.82% |
| Curatis Holding AGSWX: CURN | $125.99M | CHF19.70 | +12.57% |
| Kopran LimitedBSE: 524280 | $125.38M | Rs251.30 | -10.97% |
| Vikram Thermo (India) LimitedBSE: 530477 | $124.99M | Rs385.75 | -4.96% |
| Orient EuroPharma Co., Ltd.TPEX: 4120 | $124.80M | NT$46.00 | -0.22% |
Figures last refreshed Oct 11, 2026.